Centro de Recursos

Esta sección contiene investigaciones internacionales y puede hacer referencia a indicaciones que no están aprobadas en todas las regiones. Consulte las indicaciones aprobadas localmente antes de su uso.

Filtrado por:

Buscar
What an incredible experience at Royal Australian and New Zealand College of Obstetricians and Gynaecologists RANZCOG 2025!
RAMAT GAN, Israel, Nov. 3, 2025 /PRNewswire/ -- Pulsenmore Ltd. (TASE: PULS), a pioneer in home ultrasound solutions, today announced that the U.S. Food and Drug Administration (FDA) has granted
Innovation happens when clinicians and technology come together.
Stop by the GE HealthCare booth to experience Pulsenmore
Pulsenmore (TASE: PULS), a pioneering provider of home-based ultrasound technology, has announced the renewal and expansion of its strategic partnership with Clalit Health Services, Israel's largest HMO. Over the next
Pulsenmore secured a commercial agreement with Sheba Medical Center, Tel Hashomer for remote patient monitoring of highrisk pregnancies using its’ home ultrasound solution. Sheba Medical Center, will utilize Pulsenmore's solution

The News Pulse

Le invitamos a mantenerse al día con las más recientes actualizaciones registrándose a nuestro boletín trimestral

Preguntas frecuentes

Preguntas frecuentes